###begin article-title 0
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Immunization with thyroglobulin induces Graves'-like disease in mice
###end article-title 0
###begin p 1
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 278 279 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 302 303 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 335 336 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1044 1045 1044 1045 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1052 1053 1052 1053 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1067 1070 1067 1070 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 29 35 <span type="species:ncbi:9913">bovine</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
###xml 972 976 <span type="species:ncbi:10090">mice</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
###xml 1315 1319 <span type="species:ncbi:10090">mice</span>
###xml 1441 1445 <span type="species:ncbi:10090">mice</span>
We immunized AKR/N mice with bovine thyroglobulin (Tg) once every 2 weeks and monitored their time-dependent changes in 125I uptake activity in the thyroid glands. After 3 months, anti-Tg antibody was positive in all sera from the immunized mice. Serum free tri-iodothyronine (T3) and free thyroxine (T4) levels in the immunized mice (n=6) were significantly higher than those in the saline injected (control) mice (n=6). Neck counts as well as scintigraphy of the thyroid glands revealed that iodide uptake activity of the immunized mice was not suppressed, but was instead higher than that of the control mice. Two of the six immunized mice showed extremely high iodide uptake activity. The thyroid glands of these two mice were diffusely enlarged and the height of the epithelial cells was also increased. In addition, two mice with high iodide uptake activity produced a high titer of thyroid-stimulating antibody. Additional experiments showed that 4 out of 11 AKR/N mice and 3 out of 10 C57BL6 mice immunized with Tg had high serum free T3/free T4 levels, high 125I uptake activity of the thyroid, and positive thyroid-stimulating antibody activity. Diffuse goiter, thyrotoxicosis, high iodide uptake activity, and positive thyroid-stimulating antibody are the characteristics of Graves' disease. Thus, these mice exhibit the symptoms of Graves' disease. These results suggest that immunization with Tg induces Graves'-like disease in mice and that our methods will provide a new animal model of Graves' disease.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 260 278 260 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Kasagi <italic>et al</italic>. 1993</xref>
###xml 199 206 <span type="species:ncbi:9606">patient</span>
Both Graves' disease and chronic autoimmune thyroiditis belong to the family of autoimmune thyroid diseases. However, Graves' disease may precede or follow chronic autoimmune thyroiditis in the same patient, presumably related by similar autoimmune processes (Kasagi et al. 1993).
###end p 3
###begin p 4
###xml 224 244 224 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Dayan &amp; Daniels 1996</xref>
###xml 382 387 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 373 393 369 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Bottazzo <italic>et al</italic>. 1983</xref>
###xml 485 490 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 476 496 472 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Hamilton <italic>et al</italic>. 1991</xref>
###xml 831 850 827 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Kohn &amp; Shifrin 1982</xref>
###xml 499 507 <span type="species:ncbi:9606">Patients</span>
Chronic autoimmune thyroiditis is characterized by serum autoantibodies against thyroglobulin (Tg) and thyroid peroxidase (TPO), and histologically by fibrosis and varying degrees of lymphocytic infiltration in the thyroid (Dayan & Daniels 1996). The appearance of MHC class II molecules on thyroid cells which has been correlated with gamma-interferon-containing T cells (Bottazzo et al. 1983), has been thought to be the initiating factor in chronic autoimmune thyroiditis (Hamilton et al. 1991). Patients with Graves' disease also produce autoantibodies against Tg and TPO, and the disease is characterized by thyroid-stimulating autoantibody (TSAb) against thyrotropin receptor (TSHR). This functional autoantibody stimulates hormone synthesis, secretion, and cell growth, and induces thyrotoxicosis and goiter in the disease (Kohn & Shifrin 1982). However, the precise mechanisms in which TSHR peptides are presented as antigens still remain unclear.
###end p 4
###begin p 5
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 0 21 0 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Shimojo <italic>et al</italic>. (1996)</xref>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
Shimojo et al. (1996) succeeded in producing a mouse model of Graves' disease by immunization with fibroblasts expressing both TSHR and MHC class II molecules, after they clearly demonstrated that co-expression of MHC class II molecule and TSHR on the cell surface were necessary for producing TSAb in AKR/N mice. Therefore, clarification of the conditions or the environments that induce aberrant expression of MHC class II molecules in the antigen-presenting cells are important for understanding the pathogenesis of Graves' disease.
###end p 5
###begin p 6
###xml 226 230 <span type="species:ncbi:10090">mice</span>
We hypothesize here that pathological conditions such as autoimmune thyroiditis and lymphocytic infiltration in thyroid glands must precede the production of TSAb. Thus, we have produced experimental autoimmune thyroiditis in mice by immunizing them with Tg and we monitored the iodide uptake activity of their thyroid glands. We found that some of them exhibited the symptoms of Graves' disease.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
Animals and immunization with Tg
###end title 8
###begin p 9
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 328 334 <span type="species:ncbi:9913">Bovine</span>
###xml 541 546 <span type="species:ncbi:10090">mouse</span>
All studies performed were approved by the Animal Research Committee, Yamanashi University. Female AKR/N mice and C57BL6 mice were obtained from CLEA Japan, Inc., Tokyo, Japan. All mice were specific pathogen free and checked for pathogens once every 2 months. All mice were 12-14 weeks old at the beginning of the experiments. Bovine Tg (0.5 mg/ml) purchased from Sigma-Aldrich Chemical Co. or saline was emulsified with the same volume of complete Freund's adjuvant (Wako Chemical Co., Tokyo, Japan) and then 50 mul emulsion (25 mug of Tg/mouse) was injected into the soleus muscle once every 2 weeks.
###end p 9
###begin p 10
All immunizations were performed in the presence of complete Freund's adjuvant.
###end p 10
###begin title 11
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
125I uptake and measurement of thyroid hormones
###end title 11
###begin p 12
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 768 769 766 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 800 801 798 799 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
125I-Na (3.7 GBq/ml) was obtained from GE Healthcare, Japan. The solution was at first diluted with sterile saline to 9.25x104 Bq/100 mul. In experiment 1, 100 mul of this diluted solution was administrated into the peritoneal space at 1-3 months after the first immunization. After 24 h, the mice were anesthetized with pentobarbital and the iodide uptake into the thyroid glands was monitored by neck counter and scintigraphy. In experiments 2 and 3, we did not carry out the monitoring of thyroid iodide uptake activities. At 3 months after the first immunization, accurate radioactivity of the resected thyrotracheal unit was also measured with a gamma-counter (Aloka, Autowell Gamma System, Model ARC-380, Tokyo, Japan) in all experiments. Serum free thyroxine (T4) and free tri-iodothyronine (T3) levels were assayed by an ECLusis system (Roche Diagnostic Co).
###end p 12
###begin title 13
Detection of anti-Tg antibody and assay for thyroid-stimulating antibody activity
###end title 13
###begin p 14
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 455 473 455 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Ohmori <italic>et al</italic>. 1991</xref>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
Detection of antibody against Tg and TPO was carried out with a commercial detection kit (Cosmic Co., Tokyo, Japan). For measuring TSAb activity, mouse IgG was partially purified with polyethylene glycol and the activity was assayed using a commercial kit for TSAb (Yamasa Shoyu Co., Chiba, Japan). Thyroid-stimulating antibody activity (%) was calculated as follows: (cAMP increase by test IgG/cAMP increase by control IgG)x100, as previously described (Ohmori et al. 1991). The cut-off value was set as 180%.
###end p 14
###begin title 15
Results
###end title 15
###begin p 16
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 302 308 302 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 861 864 861 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 1088 1094 1088 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 144 150 <span type="species:ncbi:9913">bovine</span>
###xml 551 556 <span type="species:ncbi:10090">mouse</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
###xml 1082 1086 <span type="species:ncbi:10090">mice</span>
We divided female AKR/N mice into three groups (experiment 1). The first group was non-treated (n=6); the second group (n=6) was immunized with bovine Tg and the third (n=6) was injected with saline once every 2 weeks; the 125I uptake activity of their thyroid glands was then measured by neck counts (Fig. 1a). At 1 month after the first immunization, no significant difference in iodide uptake activity was observed between these three groups. Although no significant difference in the mean uptake activity between the groups was found at 2 months, mouse No. 1 in the immunized group showed high iodide uptake activity and this gradually increased. At 3 months, two out of six mice immunized with Tg showed higher iodide uptake activity than those of the other four mice in the same group. Thyroid scintigraphy carried out at that time also demonstrated that 125I uptake activity of the thyroid glands in mice No. 1 and No. 2 in the Tg immunized group was higher than those of the other four mice of the same group and also higher than those of the non-treated or saline injected mice (Fig. 1b).
###end p 16
###begin p 17
###xml 149 156 149 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 375 376 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 491 492 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 504 505 504 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 514 522 514 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 803 809 803 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 1089 1095 1083 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 1189 1190 1183 1184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1201 1202 1195 1196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1252 1253 1246 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1308 1314 1302 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 1327 1328 1321 1322 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1442 1448 1436 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 1453 1460 1447 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1663 1670 1657 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1770 1777 1764 1771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 995 999 <span type="species:ncbi:10090">mice</span>
###xml 1227 1231 <span type="species:ncbi:10090">mice</span>
###xml 1302 1306 <span type="species:ncbi:10090">mice</span>
###xml 1339 1343 <span type="species:ncbi:10090">mice</span>
###xml 1410 1414 <span type="species:ncbi:10090">mice</span>
###xml 1480 1484 <span type="species:ncbi:10090">mice</span>
###xml 1598 1602 <span type="species:ncbi:10090">mice</span>
###xml 1616 1620 <span type="species:ncbi:10090">mice</span>
###xml 1716 1720 <span type="species:ncbi:10090">mice</span>
Three months after the first immunization, we examined their thyroid functions, histology of the glands, and presence of autoantibodies in the sera. Table 1 shows the radioiodide counts of the resected thyrotracheal units measured by a gamma counter. The mean iodide uptake of the immunized mice was significantly higher than that of the non-treated or saline-injected mice (P<0.05). Particularly, radioactivities from mice No. 1 and No. 2 in the immunized group were extremely high (4.72x106 and 4.82x106 c.p.m). Figure 2a shows that those thyroid glands having high iodide uptake activity were diffusely enlarged compared with those of the saline-injected mice. Microscopic examination of the tissues revealed that the height of the epithelial cells in mice No. 1 and No. 2 was increased, as shown in Fig. 2c, which is a characteristic feature of Graves' disease. When we compared the mean height of 500 epithelial cells from the immunized mice with that of 500 cells from the saline-injected mice, the former (6.58+/-0.08 mum) was significantly taller than the latter (3.03+/-0.08 mum; Fig. 2e). No prominent lymphocyte infiltration was observed among the tissues. The mean serum free T3 and free T4 levels of the immunized mice were significantly (P<0.001) higher than those of the saline-injected mice (Fig. 3). The free T3 levels in mice No. 1 and No. 2 were markedly higher than those of the other four mice in the Tg immunized group (Fig. 3 and Table 1). All Tg immunized mice produced anti-Tg antibody in their sera, but no activity was observed in the non-treated and the saline-injected mice. None of the mice produced anti-TPO antibody in their sera (Table 1). Interestingly, the TSAb values produced by mice No. 1 and No. 2 were 1320 and 391% respectively (Table 1).
###end p 17
###begin p 18
###xml 104 105 104 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 116 117 116 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 332 335 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 406 407 406 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 418 419 418 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 514 517 514 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 594 595 592 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 692 693 688 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 779 780 775 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 838 845 834 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 46 52 <span type="species:ncbi:9913">bovine</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
Additionally, we immunized 11 AKR/N mice with bovine Tg, and 3 months later, measured their serum free T3 and free T4 levels, 125I uptake activity in the thyroid glands, and TSAb activity (experiment 2). In this experiment, we omitted monitoring of thyroid iodide uptake activities of mice by neck counter, so we did not administer 125I at 1 and 2 months after the first immunization. The mean serum free T3 and free T4 levels from immunized mice were significantly higher than those of the control mice. The mean 125I uptake activity in the thyroid glands of the immunized mice (3.68+/-0.20x106 c.p.m.) was not suppressed, but was instead higher than that of the control mice (1.99+/-0.08x106 c.p.m). We also observed that 4 out of the 11 immunized mice with a high serum free T3 level (Tg 4, 6, 8, and 11) possessed high TSAb activity (Table 1).
###end p 18
###begin p 19
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 205 206 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 217 218 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 235 238 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 358 365 358 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 395 396 395 396 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 407 408 407 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 102 108 <span type="species:ncbi:9913">bovine</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">Mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
To know whether our observation is specific to the AKR/N strain, we immunized C57BL6 mice (n=10) with bovine Tg using the same protocol (experiment 3). Again, we obtained the results that mean serum free T3 and free T4 levels and mean 125I uptake activity in the thyroid glands of the immunized mice were significantly higher than those of the control mice (Table 1). Mice with high serum free T3 and free T4 levels exhibited high TSAb activity (Tg 2, 5, and 6), suggesting that immunization with Tg also produce Graves'-like disease in C57BL6 mice.
###end p 19
###begin title 20
Discussion
###end title 20
###begin p 21
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 197 216 197 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Shimojo <italic>et al</italic>. 1996</xref>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 345 361 345 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Endo <italic>et al</italic>. 1995</xref>
There exists a consensus that TSAb plays a central role in the pathogenesis of Graves' disease. The autoantibody stimulates thyroid epithelial cells like TSH and induces thyrotoxicosis and goiter (Shimojo et al. 1996). We previously reported the expression of TSHR in fat cells, the level of which is almost comparable with that in the thyroid (Endo et al. 1995). The development of exophthalmos and pretibial myxedema is attributable to the autoantibody against TSHR.
###end p 21
###begin p 22
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 104 120 104 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Endo <italic>et al</italic>. 1991</xref>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 137 159 137 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Kaithamana <italic>et al</italic>. 1999</xref>
###xml 202 207 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 194 213 194 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Shimojo <italic>et al</italic>. 1996</xref>
###xml 272 277 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 260 283 260 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Costagliola <italic>et al</italic>. 2000</xref>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 315 335 315 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Nagayama <italic>et al</italic>. 2002</xref>
###xml 983 988 983 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 974 994 974 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Hanafusa <italic>et al</italic>. 1983</xref>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
Recently, many groups have developed animal models of Graves' disease by immunizing with TSHR peptides (Endo et al. 1991), TSHR protein (Kaithamana et al. 1999), or TSHR-expressing fibroblasts (Shimojo et al. 1996), or by using the expression plasmid of TSHR (Costagliola et al. 2000) and adenovirus-mediated TSHR (Nagayama et al. 2002). All of these data support that TSHR autoantibody is the cause of Graves' disease. Thus, our next concern was the antigen-presenting mechanism of TSHR in its autoimmune process. From this point of view, Shimojo's model is extremely important, because the co-existence of MHC class II molecules and TSHR on the cell surface of fibroblasts can produce TSAb in mice, but not the co-existence of MHC class I molecules and TSHR. The evidence supports the previous hypothesis that aberrant expression of MHC class II molecule on thyroid epithelial cells may trigger a cascade of self-directed, uncontrolled immune response in Graves' disease (Hanafusa et al. 1983).
###end p 22
###begin p 23
However, it is still controversial whether TSHR peptides are presented as antigens by specifically antigen-presenting cells (macrophages) or by other cells (thyroid epithelial cells). In the former, destructive or degenerative changes of thyroid epithelial cells may precede the process, and in case of the latter, infiltration of gamma-interferon containing T cells may precede the process.
###end p 23
###begin p 24
###xml 0 20 0 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Twarog &amp; Rose (1968)</xref>
###xml 485 505 485 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Vladutiu &amp; Rose 1971</xref>
###xml 699 723 699 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Vladutiu &amp; Kenney (1985)</xref>
###xml 862 863 862 863 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 931 932 931 932 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 254 259 <span type="species:ncbi:10090">mouse</span>
###xml 541 546 <span type="species:ncbi:10090">mouse</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 1065 1069 <span type="species:ncbi:10090">mice</span>
Twarog & Rose (1968) produced experimental autoimmune thyroiditis in mice by immunizing mice with thyroid extracts emulsified with Freund's complete adjuvant. After that, this disease has been readily induced in many strains of mice by immunization with mouse Tg emulsified in Freund's complete adjuvant. In some strains (low responders to Tg), there is only minor thyroid damage after immunization with Tg, whereas in other strains (high responders), the thyroid damage is extensive (Vladutiu & Rose 1971). It is widely believed that these mouse models of autoimmune thyroiditis are in a hypothyroid state, but there are few studies of thyroid function in mice with induced autoimmune thyroiditis. Vladutiu & Kenney (1985) investigated the thyroid function of mice immunized with Tg. They found that in all mice (low and high responders), the lowest levels of T4 were observed 2 weeks after immunization, and in the fourth week, T4 concentration was, surprisingly and inexplicably, higher than the pre-immunization values. We demonstrate here that immunization of mice with Tg induces thyrotoxicosis. A detailed comparison of our data with that of Vladutiu & Kenney is difficult because their experimental conditions and protocols were different from ours, but thyrotoxicosis might occur after 4 weeks from the first immunization with Tg.
###end p 24
###begin p 25
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
However, iodide uptake activity of Tg immunized mice was not suppressed, but was instead enhanced, so it is unlikely that the increase of serum thyroid hormone levels was merely due to the destruction of thyroid epithelial cells. The phenomenon was observed not only in AKR/N mice (high responders) but also in C57BL6 mice (low responders), suggesting that it is not strain specific. In addition, some of the Tg immunized AKR/N mice as well as C57BL6 mice had high iodide uptake activity and high titers of TSAb.
###end p 25
###begin p 26
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 466 484 466 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Hovens <italic>et al</italic>. 2007</xref>
###xml 537 540 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 741 744 741 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
###xml 247 252 <span type="species:ncbi:9606">human</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
###xml 1012 1016 <span type="species:ncbi:10090">mice</span>
###xml 1105 1109 <span type="species:ncbi:10090">mice</span>
To obtain clear thyroid image with short exposure time to the imaging plate, we administrated 9.25x104 Bq of 125I to each mouse in experiment 1, the dose (4.6 MBq/kg) of which is almost comparable with that used for therapy for Graves' disease in human. Recently, it has been reported that TSAb may occur shortly after radioiodine therapy in toxic multinodular goiter, in which pre-existing autoimmunity may not be a requirement for the induction of the antibodies (Hovens et al. 2007). So the possibility remains that administration of 125I to mice in the course of experiment 1 might induce TSAb in these mice. However, in experiments 2 and 3, we omitted monitoring of thyroid iodide uptake activities by neck counter so, we administrated 125I to the animals only at 3 months point. Thus, we think it likely that Graves'-like disease in these mice was induced by immunization of Tg. It would be important to know whether immunization with other thyroid antigens such as TPO also induce Graves' like disease in mice. However, our results suggest that immunization with Tg induces Graves'-like disease in mice and also that the pathogenesis of two disorders are closely related.
###end p 26
###begin title 27
Declaration of interest
###end title 27
###begin p 28
The authors declare no conflict of interest.
###end p 28
###begin title 29
Funding
###end title 29
###begin p 30
This research received funding from the Basic Research Fund (C) of the Ministry of Education, culture, sports, Japan (Grant number 21591127) to TE.
###end p 30
###begin title 31
References
###end title 31
###begin article-title 32
Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity
###end article-title 32
###begin article-title 33
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease
###end article-title 33
###begin article-title 34
Chronic autoimmune thyroiditis
###end article-title 34
###begin article-title 35
###xml 32 38 <span type="species:ncbi:9986">rabbit</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
Thyroid stimulating activity of rabbit antibodies toward the human thyrotropin receptor peptide
###end article-title 35
###begin article-title 36
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Cloning and functional expression of a thyrotropin receptor cDNA from rat fat cells
###end article-title 36
###begin article-title 37
###xml 134 139 <span type="species:ncbi:9606">human</span>
Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma-containing lymphocytes in human thyroid autoimmune disease
###end article-title 37
###begin article-title 38
Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity
###end article-title 38
###begin article-title 39
Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay
###end article-title 39
###begin article-title 40
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Induction of experimental autoimmune Graves' disease in BALB/c mice
###end article-title 40
###begin article-title 41
Thyrotropin receptor antibodies in hypothyroid Graves' disease
###end article-title 41
###begin article-title 42
Receptor structure and function: an exploratory approach using the thyrotropin receptor as a vehicle
###end article-title 42
###begin article-title 43
###xml 8 14 <span type="species:ncbi:10090">murine</span>
A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor
###end article-title 43
###begin article-title 44
###xml 15 22 <span type="species:ncbi:9031">chicken</span>
###xml 45 50 <span type="species:ncbi:9606">human</span>
Development of chicken antibodies toward the human thyrotropin receptor peptides and their bioactivities
###end article-title 44
###begin article-title 45
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule
###end article-title 45
###begin article-title 46
###xml 44 48 <span type="species:ncbi:10090">mice</span>
The production of thyroid autoantibodies in mice
###end article-title 46
###begin article-title 47
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Thyroid function in mice with experimental autoimmune thyroiditis
###end article-title 47
###begin article-title 48
Autoimmune thyroiditis: correlation with histocompatibility (H-2) type
###end article-title 48
###begin p 49
(T Endo and T Kobayashi contributed equally to this work)
###end p 49
###begin p 50
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 162 165 162 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 576 579 576 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
125I uptake activity in mice immunized with thyroglobulin and control mice. (a) Time-dependent changes in 125I uptake activity in mice measured with neck counts. 125I-Na was administered into the peritoneal space of the non-treated mice (triangles), thyroglobulin immunized mice (filled circles) and the saline injected mice (open circles), and after 24 h, the radioactivity was monitored by neck counts. The activity was indicated as a percentage of the total counts administered. (b) Scintigraphy of the thyroid glands was carried out 3 months after the first immunization. 125I-Na was administered to mice in the same way as in (a). After 24 h, mice were exposed to the imaging plate for 1 min and the images were then analyzed using BAS 2500 systems (Fujix, Tokyo, Japan). Upper six thyroid images (Nos 1-6) were those of the control (saline injected) mice, and the lower six images (Nos 1-6) were those of the Tg immunized mice. White and black arrows indicate the location of submandibular glands and thyroid glands respectively.
###end p 50
###begin p 51
###xml 622 623 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
###xml 208 210 <span type="species:ncbi:10090">S1</span>
###xml 285 290 <span type="species:ncbi:10090">mouse</span>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
###xml 330 332 <span type="species:ncbi:10090">S1</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
Morphological changes of the thyroid glands of mice immunized with thyroglobulin. (a) Thyroid glands of a mouse immunized with thyroglobulin (Tg1) are diffusely enlarged. (b) Control (saline injected) mouse (S1). (c and d) Hematoxylin-eosin staining of the sections from the immunized mouse (Tg1) (c, x100) and the control mouse (S1) (d, x100). (e) Height of epithelial cells of the immunized mice with that of the control mice. The heights of 500 epithelial cells from control mice and those from immunized mice were measured after amplifying their digital images. Statistical analysis was carried out with the Student's t-test.
###end p 51
###begin p 52
###xml 12 13 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 203 204 203 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 219 220 219 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 334 340 332 338 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s.e.m.</sc>
###xml 342 343 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Serum free T3 and free T4 levels in mice immunized with thyroglobulin and saline injected (control) mice. At 3 months after the first immunization, the sera were obtained by heart puncture and the free T3 (a) and free T4 (b) levels were determined as described in the Materials and methods section. The values are indicated as mean+/-s.e.m. *P<0.05.
###end p 52
###begin p 53
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Thyroid functions of mice immunized with thyroglobulin and control mice
###end p 53
###begin p 54
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 120 126 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 126 127 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
N, non-treated mice; S, control (saline) mice; Tg, thyroglobulin immunized mice. *P<0.001 versus control (saline) mice. daggerP<0.05 versus control (saline) mice.
###end p 54
###begin p 55
Radioactivity of the thyro-tracheal unit measured by a gamma counter.
###end p 55

